Earlier this month, the U.S. Food and Drug Administration (FDA) approved Ixchiq, the world’s first licensed vaccine for the mosquito-borne chikungunya virus. The single-dose vaccine was ...
The world's first vaccine to protect against chikungunya virus, which is spread by mosquitoes, was just approved by the U.S. Food and Drug Administration (FDA). "Infection with chikungunya virus ...
The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot, known as Ixchiq, is approved for adults ...
FRIDAY, Nov. 10, 2023 (Healthday News) -- The first vaccine to prevent infection with the chikungunya virus was approved by the U.S. Food and Drug Administration on Thursday. The single-dose shot ...
The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva Austria's parent company is France's Valneva SE.
Nov. 10, 2023 -- The FDA on Thursday approved the first vaccine for the chikungunya virus, which is transmitted to humans through mosquito bites. The vaccine, called Ixchiq and produced by Valneva ...
A first of its kind vaccine has been approved by the FDA to prevent infections with the chikungunya virus. The virus is most prevalent in semi-tropical and tropical areas, such as Central and ...
Nov 10 (Reuters) - French drugmaker Valneva said on Friday the U.S. Food and Drug Administration (FDA) has approved its Chikungunya single-dose vaccine in individuals aged 18 and above. The ...
(RTTNews) - Valneva SE (VALN) Friday said its chikungunya vaccine, IXCHIQ for people aged 18 and above, has been approved by the Food and Drug Administration (FDA). This makes IXCHIQ the world's ...
Valneva (NASDAQ:VALN) announced on Friday its Ixchiq single-dose, live-attenuated vaccine against the chikungunya virus was approved by the U.S. FDA. Ixchiq is the world's first vaccine against ...
Nov 9 (Reuters) - The U.S. Food and Drug Administration (FDA) on Thursday approved Valneva's (VLS.PA) single-shot vaccine for individuals 18 years of age and older who are at increased risk of ...
